Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities: Proceedings from a conference organised by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, held in Vatican City, May 22-23, 2025.
Ringborg U, von Braun J, Celis J, Berns A, Baumann M, Albreht T, Abou-Zeid N, Bagnato V, Brandts C, Chen CJ, di Pietro M, Dosanjh M, Dubois T, Eggermont A, Eggert A, Ernberg I, Faithfull S, Förner J, Fröhling S, Heitor M, Hood L, Jiang W, Jönsson B, Kannan R, Leptin M, Li S, Lindgren P, Lowy D, Ma J, Markham A, Nagy P, Oberst S, Parker MI, Rodin D, Ryan K, Schüz J, Sullivan R, Tabernero J, Turkson P, Várhelyi O, Varmus H, Wang C, Weiderpass E, Wilking N.
Ringborg U, et al. Among authors: celis j.
Mol Oncol. 2025 Dec 15. doi: 10.1002/1878-0261.70179. Online ahead of print.
Mol Oncol. 2025.
PMID: 41397948
Free article.